ANZIC Research Center, School of Public Health & Preventive Medicine, Monash University, The Alfred Center, 99 Commercial Road, Melbourne, VIC, 3004, Australia.
Ann Intensive Care. 2013 Jan 15;3(1):2. doi: 10.1186/2110-5820-3-2.
Red blood cells (RBC) storage facilitates the supply of RBC to meet the clinical demand for transfusion and to avoid wastage. However, RBC storage is associated with adverse changes in erythrocytes and their preservation medium. These changes are responsible for functional alterations and for the accumulation of potentially injurious bioreactive substances. They also may have clinically harmful effects especially in critically ill patients. The clinical consequences of storage lesions, however, remain a matter of persistent controversy. Multiple retrospective, observational, and single-center studies have reported heterogeneous and conflicting findings about the effect of blood storage duration on morbidity and/or mortality in trauma, cardiac surgery, and intensive care unit patients. Describing the details of this controversy, this review not only summarizes the current literature but also highlights the equipoise that currently exists with regard to the use of short versus current standard (extended) storage duration red cells in critically ill patients and supports the need for large, randomized, controlled trials evaluating the clinical impact of transfusing fresh (short duration of storage) versus older (extended duration of storage) red cells in critically ill patients.
红细胞(RBC)储存有助于供应 RBC,以满足输血的临床需求并避免浪费。然而,RBC 储存会导致红细胞及其保存介质发生不良变化。这些变化会导致功能改变和潜在有害生物活性物质的积累。它们还可能对危重症患者产生临床有害影响。然而,储存损伤的临床后果仍然存在持续争议。多项回顾性、观察性和单中心研究报告了关于血液储存时间对创伤、心脏手术和重症监护病房患者发病率和/或死亡率影响的异质性和相互矛盾的发现。本综述描述了这一争议的细节,不仅总结了当前的文献,还强调了目前在危重症患者中使用短时间与当前标准(延长)储存时间红细胞的平衡,并支持需要进行大型、随机、对照试验,以评估在危重症患者中输注新鲜(储存时间短)与陈旧(储存时间长)红细胞的临床影响。